Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
74.3M
-
Shares change
-
+1.9M
-
Total reported value, excl. options
-
$3.73B
-
Value change
-
+$99.2M
-
Put/Call ratio
-
1.36
-
Number of buys
-
110
-
Number of sells
-
-77
-
Price
-
$50.20
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q3 2022
225 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q3 2022.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.3M shares
of 79.2M outstanding shares and own 93.78% of the company stock.
Largest 10 shareholders include FMR LLC (10.7M shares), WELLINGTON MANAGEMENT GROUP LLP (7.49M shares), VANGUARD GROUP INC (7.21M shares), BlackRock Inc. (6.11M shares), RTW INVESTMENTS, LP (5.62M shares), FRANKLIN RESOURCES INC (4.47M shares), ARMISTICE CAPITAL, LLC (2.9M shares), STATE STREET CORP (2.82M shares), Camber Capital Management LP (2.45M shares), and JANUS HENDERSON GROUP PLC (2.08M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.